Summary of CANTEL MEDICAL CORP

Change in Directors or Principal Officers, Financial Statements and Exhibits

Item 5.02 Departure of Directors or Principal Officers; Election of
Directors, Appointment of Principal Officers

On March 18, 2009, the Board of Directors of the Company promoted Andrew A. Krakauer, President of the Company, to President and Chief Executive Officer. Mr. Krakauer will also become a member of the Board of Directors.

Mr. Krakauer (54) has served as President and a member of the Office of the Chairman since April 23, 2008. Prior to that, he served as Executive Vice President and COO since joining the Company in September 2004. Before joining Cantel, Mr. Krakauer served as President of the Ohmeda Medical Division of Instrumentarium / GE Healthcare. Before being named President of Ohmeda Medical in 1998, Mr. Krakauer served Ohmeda or its predecessor companies as President of the Specialty Products Division and Business Development from 1994 through 1998, General Manager of the Suction and Oxygen Therapy and Infant Care businesses from 1988 through 1994, and in a series of financial and business development positions from 1980 through 1987. Mr. Krakauer holds an MBA from University of Chicago and a BA from SUNY at Binghamton.

The Board concurrently appointed Seth R. Segel, Senior Vice President - Strategy and Corporate Development, to the position of Executive Vice President and Craig
A. Sheldon, Senior Vice President - CFO, to the position of Senior Vice President - CFO and Treasurer. In addition, Board member George Fotiades was named Vice Chairman, replacing Alan Hirschfield, who retired from such position on March 18th but remains an active Board member. Mr. Fotiades, who joined the Board in May 2008, will also become a member of the Office of the Chairman, joining Charles M. Diker, Chairman of the Board, along with Messrs. Krakauer and Segel. The new appointments became effective on March 18, 2009.